Latest Management of cancer Stories
Cancer research has truly gone to the dogs as scientists at the University of Illinois have announced the start of phase I trials for a drug showed good results in the treatment of spontaneously occurring cancers in pet dogs.
VANCOUVER, Canada and HOUSTON, TX, Feb. 27, 2015 /PRNewswire/ - ESSA Pharma Inc. ("ESSA" or the "Company") (TSX-V: EPI) and Bloom Burton & Co. Ltd.
HOUSTON, TX and VANCOUVER, Feb. 25, 2015 /PRNewswire/ - ESSA Pharma Inc.
DALLAS, February 25, 2015 /PRNewswire/ -- MarketReportsOnline.com adds "Global Radiation Therapy Market Report: 2015 Edition" report that says worldwide radiation therapy
- New, long-term preliminary data from Phase II STAND trial to be presented at 2015 Genitourinary Cancers Symposium (ASCO GU) LAVAL, Quebec, Feb.
Abstracts: 160, 182, 195, 202, 247, 253, 254 WHIPPANY, N.J., Feb. 23, 2015 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals Inc.
Ken Burns Presents "CANCER: THE EMPEROR OF ALL MALADIES" Directed by Barak Goodman WHITE PLAINS, N.Y., Feb.
A Follow-On Combination Trial in First-Line Ovarian Cancer in the Neo-Adjuvant Setting Has Been Accepted by FDA LAWRENCEVILLE, N.J., Feb.
DUBLIN, Feb .11, 2015 /PRNewswire/ --Research and Markets (http://www.researchandmarkets.com/research/ptgkrh/drug_delivery_in)
Journal of Clinical Oncology Research Looks at Value, Risk of Aggressive Surgery Pittsburgh, PA (PRWEB) February 10, 2015 Aggressive surgery to remove
- Withering but not falling off, as a blossom that persists on a twig after flowering.